The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data

20251 citationsJournal Articlegold Open Access

Authors

Nina L Wittwer · University Hospital of Basel

Christoph Meier · Boston Collaborative Drug Surveillance Program

Carola A. Huber · Helsana Group (Switzerland)

Justin C. Moser · University of Basel

Henriette E. Meyer zu Schwabedissen · University of Basel

Samuel Allemann · University of Basel

Cornelia Schneider

Abstract

In light of the high prevalence of the simultaneous use of PGx drugs with inhibitor and inducer drugs, it is imperative to consider non-genetic factors, such as drug-induced phenoconversions, when interpreting PGx test results.

Topics & Keywords

Pharmacogenetics and Drug Metabolism Statistical Methods in Clinical Trials Computational Drug Discovery Methods

Publication Details

Published in: Pharmacogenomics and Personalized Medicine

Volume Volume 18, pp. 197-208

DOI: 10.2147/pgpm.s527556

Field-Weighted Citation Impact: 1.74

Command Palette

The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data

Authors

Abstract

Topics & Keywords

Publication Details